Aveo Capital Partners’s Celgene Corp CELG Stock Holding History

Aveo Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,114	Closed	-$245K	–	247
2016 Q4	$245K	Buy	+2,114	New	+$235K	0.07%	180

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aveo Capital Partners's CELG Position: Q1 2017 in Review

Aveo Capital Partners sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 2,114 shares — an estimated $245K sold.

Aveo Capital Partners first reported a position in CELG in Q4 2016 and held it in 1 quarter. The position peaked at $245K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Aveo Capital Partners reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Aveo Capital Partners sold 2,114 Celgene Corp shares in Q1 2017, an estimated $245K.
Aveo Capital Partners first reported a position in Celgene Corp in Q4 2016 and held it in 1 quarter.
Aveo Capital Partners's Celgene Corp position peaked at $245K in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Aveo Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.